JYNT

Over the past six months, The Joint Corp.'s stock price has fluctuated, showing a 3.30% increase over that period but a 0.12% decrease in the past month as of September 18, 2026. The stock experienced its largest daily move with a 7.9% increase on June 11, 2026. Key events impacting the stock include the Q2 2026 financial results reported on August 6, 2026, where adjusted EPS of $0.05 beat forecasts, and revenue rose 14% year-over-year to $15.2 million, surpassing consensus, with adjusted EBITDA significantly increasing to $1.5 million. Management also cut its full-year new clinic openings guidance to 22-26 from 30-35. System-wide sales fell 3.7%, and comparable sales declined 2.8% in Q2 2026. The company is advancing its capital-light franchising model, with refranchising expected to be completed in the second half of 2026, aiming to improve margins and free cash flow, despite a decline in clinic count due to the closure of underperforming locations.